Volume 6, Number 3:27-42;2017
American Journal of Clinical and Experimental Immunology


Tam NM Dinh, Alexandra S Onea, Ali R Jazirehi: Combination of celecoxib (Celebrex®) and CD19 CAR-redirected CTL immunotherapy for the treatment of B-cell non-Hodgkin’s lymphomas. Am J Clin Exp Immunol 2017;6(3):27-42. (Full text, PDF).
AJCEI Copyright © 2012-present, All rights reserved. Published by e-Century Publishing Corporation, Madison, WI 53711, USA